Dri Healthcare Trust T.DHT.UN

Revised Targets

[retiredcf]

Canaccord Genuity’s Tania Armstrong-Whitworth cut her DRI Healthcare Trust  target to $16.25 from $17 with a “buy” rating, while CIBC’s Scott Fletcher lowered his target to $18 from $20 with an “outperformer” rating. The average is $18.25.

[retiredcf]

More from Canaccord. GLTA “We believe this latest round, especially as it comes on the heels of the July raise, corroborates management’s messaging that its pipeline is more robust than ever,” said Ms. Armstrong-Whitworth. “The drug royalty space has been extremely active this year given continued weakness across equity markets, particularly for biotechs. We view the timing favourably as shares